{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:57:37Z","timestamp":1789617457624,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jaad.2019.12.026","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:30:04Z","timestamp":1576888204000},"page":"1135-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular testing in metastatic basal cell carcinoma"],"prefix":"10.1016","volume":"85","author":[{"given":"Babette J.A.","family":"Verkouteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wakkee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique J.","family":"Winnepenninckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Korpershoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antien L.","family":"Mooyaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An K.L.","family":"Reyners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorrit B.","family":"Terra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.B.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie G.H.C.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Mosterd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2019.12.026_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jid.2012.431","article-title":"Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.12.026_bib2","first-page":"53","article-title":"Letter: the incidence of basal cell carcinoma and their metastases in Australia and New Zealand","volume":"14","author":"Paver","year":"1973","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.12.026_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","article-title":"Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature","volume":"10","author":"von Domarus","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.12.026_bib4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2013.3064","article-title":"Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011","volume":"149","author":"Wysong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.12.026_bib5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejca.2013.12.013","article-title":"Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease","volume":"50","author":"McCusker","year":"2014","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2019.12.026_bib6","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1158\/1078-0432.CCR-12-1956","article-title":"U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma","volume":"19","author":"Axelson","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.jaad.2019.12.026_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","article-title":"Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma","volume":"48","author":"Bonilla","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2019.12.026_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2017.08.022","article-title":"Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial","volume":"86","author":"Basset-Seguin","year":"2017","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2019.12.026_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jaad.2019.12.026_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.jaad.2019.12.026_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/archdermatol.2012.2354","article-title":"Initial assessment of tumor regrowth after vismodegib in advanced basal cell carcinoma","volume":"148","author":"Chang","year":"2012","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.12.026_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ajcp\/aqz089","article-title":"Metastatic basal cell carcinoma","volume":"152","author":"Laga","year":"2019","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2019.12.026_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-017-2121-3","article-title":"Cutaneous basal cell carcinoma with distant metastasis to thorax and bone: a clinicopathological and immunohistochemical study of 15 cases","volume":"470","author":"Weissferdt","year":"2017","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.jaad.2019.12.026_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmoldx.2016.06.010","article-title":"Reliable next-generation sequencing of formalin-fixed, paraffin-embedded tissue using single molecule tags","volume":"18","author":"Eijkelenboom","year":"2016","journal-title":"J Mol Diagn"},{"issue":"7","key":"10.1016\/j.jaad.2019.12.026_bib15","doi-asserted-by":"crossref","first-page":"e00699","DOI":"10.1002\/mgg3.699","article-title":"Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome","volume":"7","author":"Geurts-Giele","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.jaad.2019.12.026_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jmoldx.2017.11.011","article-title":"SNPitty: an intuitive web application for interactive B-allele frequency and copy number visualization of next-generation sequencing data","volume":"20","author":"van Riet","year":"2018","journal-title":"J Mol Diagn"},{"issue":"11","key":"10.1016\/j.jaad.2019.12.026_bib19","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/annonc\/mdy412","article-title":"Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics [published correction appears in Ann Oncol. 2019;30(10):1675]","volume":"29","author":"Nikanjam","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2019.12.026_bib20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/exd.12905","article-title":"Locally advanced basal cell carcinoma has a distinct methylation and transcriptomic profile","volume":"25","author":"Brinkhuizen","year":"2016","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.12.026_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaad.2018.07.004","article-title":"Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: a systematic review and meta-analysis","volume":"79","author":"Xie","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.12.026_bib22","first-page":"670","article-title":"Vismodegib (Erivedge) for advanced basal cell carcinoma","volume":"37","author":"Fellner","year":"2012","journal-title":"P T"},{"issue":"10","key":"10.1016\/j.jaad.2019.12.026_bib23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/cncy.21897","article-title":"Next-generation sequencing of cytologic preparations: an analysis of quality metrics","volume":"125","author":"Hwang","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.jaad.2019.12.026_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jid.2013.276","article-title":"Mutational landscape of basal cell carcinomas by whole-exome sequencing","volume":"134","author":"Jayaraman","year":"2014","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219333031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219333031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:06Z","timestamp":1759273146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219333031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0190962219333031"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.12.026","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular testing in metastatic basal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}